Clinical trials
Transplant clinical trials
Below are recruiting transplant clinical trials, each written for real people, not researchers. We’re tracking 1,452 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT03219359RecruitingPhase 2
Stem cell transplant using your own cells for Crohn’s flare
This Phase 2 study tests whether a transplant using your own stem cells can calm active Crohn’s disease that hasn’t improved with standard medicines. It may help some people with ongoing inflammation and symptoms after multiple Crohn’s treatments.
New York, New YorkAges 18 years+ - NCT03102125RecruitingPhase 4
Testing causes of heart transplant graft problems with scans
This study looks at why heart transplant “grafts” can start to malfunction again after transplant. If you qualify, you may undergo MRI and related heart testing to help researchers find ways to detect or understand graft dysfunction.
La Jolla, CaliforniaAges 18 years+ - NCT03292861Enrolling by invitationPhase 2
Thymoglobulin after first heart transplant: safety and effect
This trial tests whether Thymoglobulin® is safe and how well it works in people getting their first heart transplant. It may help doctors fine-tune medicines used to prevent the body from rejecting the new heart.
Los Angeles, CaliforniaAges 18–70 - NCT03128034RecruitingPhase 1/Phase 2
Astatine-211 treatment before stem cell transplant for high-risk blood cancers
This trial tests a targeted radiation drug (Astatine-211) given before a donor stem cell transplant for people with high-risk leukemia or certain bone-marrow cancers. The goal is to better control the cancer before the transplant.
Seattle, WashingtonAges 18–75 - NCT03000244Recruiting
Long-term follow-up after stem cell or gene therapy
This study checks how people do long-term after stem cell transplant, cellular therapy, or gene therapy. It may help doctors track longer-term health effects and recovery and improve future care.
Bethesda, MarylandAges 4–120 - NCT02828592RecruitingPhase 2
Transplant trial for severe aplastic anemia with related donor
This Phase 2 study tests a bone marrow transplant from a closely matched related donor, plus medicine after the transplant to help prevent immune complications. It may be an option if you have severe aplastic anemia and meet specific health and lab requirements.
Atlanta, GeorgiaAges 1–75 - NCT02846571RecruitingPhase 1/Phase 2
Diabetes cell transplant placed in the eye to restore insulin
This Phase 1/2 study tests whether transplanting insulin-producing cells into the front part of the eye can help people with diabetes. It focuses on people who already have severe, non-usable vision in one eye, to limit risk while the treatment is studied.
Miami, FloridaAges 18–75 - NCT02423070Recruiting
Study how donor genetic material behaves after lung or heart transplant
This study looks at how transplanted genetic material (DNA) changes and settles in the body after lung or heart transplant. It may help doctors understand transplant healing and improve future care for transplant recipients and candidates.
Phoenix, ArizonaAges 14–80 - NCT02641769RecruitingPhase 1/Phase 2
Stem cell injection into testicles for infertility
This trial tests whether injecting your own stem cells into your testicles can help your body start producing sperm. It is for men whose infertility is caused by a sperm-making problem rather than a blockage.
Amman, Amman GovernorateAges 21–50 - NCT02670408Recruiting
Microarrays test in heart transplant care
This study checks how special lab tests on heart tissue samples can help guide diagnosis and treatment for people with a heart transplant. You may be eligible if you already need a heart tissue biopsy for a clinical reason and can provide consent.
Los Angeles, CaliforniaAges 18 years+ - NCT02636517Enrolling by invitationPhase 1
Fecal microbiome transplant for repeat C. difficile infection
This Phase 1 study tests whether transferring healthy gut bacteria (a fecal microbiome transplant) can help children with repeated or moderate-to-severe C. difficile infection. It focuses on changing gut bacteria to reduce ongoing infection and symptoms.
Philadelphia, PennsylvaniaAges 3–21 - NCT01870752Recruiting
Transplanting frozen ovarian tissue to help you try for pregnancy
This trial studies whether thawed, previously frozen ovarian tissue can be transplanted to help people with ovarian insufficiency become pregnant. It may help if you already have cryopreserved ovarian tissue stored and your care team feels you’re a good candidate for the procedure.
Philadelphia, PennsylvaniaAges 18–45 - NCT01957696Enrolling by invitation
Study of pancreas (and sometimes kidney) transplant outcomes
This study looks at people who receive a pancreas transplant, with or without a same-time kidney transplant, and follows them to understand their results. It may help improve how transplant teams choose patients and manage care after surgery.
OsloAges 18–65 - NCT01644903Recruiting
Checking biomarkers after a liver transplant
This study follows people who are getting a liver transplant (including repeat transplants) to monitor changes in their body using test results. It may help doctors understand how patients are doing after transplant and improve care over time.
Chicago, IllinoisAges 18 years+ - NCT01531257Recruiting
Monitoring genes and health after kidney transplant
This study follows people who are getting a kidney transplant (first or later) to better understand how the body recovers, using health tracking and “gene/protein” (proteogenomic) information. It may help doctors predict complications and improve care after transplant.
Chicago, IllinoisAges 18 years+ - NCT01666080Recruiting
Second bone marrow transplant with gentler chemotherapy
This trial studies a “reduced intensity” second transplant using donated blood-forming cells, for people whose first transplant did not fully and reliably restart blood production. It aims to improve donor blood cell growth while using a less harsh conditioning approach.
Minneapolis, MinnesotaAges Up to 55 years - NCT01868373Enrolling by invitationPhase 1
Fecal transplant study for hard-to-treat C. difficile diarrhea
This Phase 1 study tests defined fecal microbiota (healthy gut bacteria) given to people with C. difficile diarrhea that didn’t go away or came back soon after antibiotics. It may help by restoring a healthier balance of gut bacteria so the infection can stop recurring.
Houston, TexasAges 18 years+ - NCT00552357Recruiting
Finding risk factors for poor lung transplant function
This study looks at what increases the chance of developing a serious complication called “primary graft dysfunction” shortly after a lung (or heart-lung) transplant. The results may help doctors better predict risk and improve care after transplant.
Philadelphia, PennsylvaniaAges 13–68 - NCT07219043RecruitingPhase 2
Felzartamab for kidney transplant patients with late microvascular inflammation
This trial tests a new medication, felzartamab, given as an infusion to help adults who received a kidney transplant and now have a type of kidney inflammation called microvascular inflammation. The goal is to see if it can slow or stop damage to the new kidney and improve its function.
Loma Linda, CaliforniaAges 18–74 - NCT07162571Enrolling by invitationPhase 1/Phase 2
Engineered immune cells for advanced leukemia or lymphoma
This study tests a new type of immune therapy called CAR-T cells, which are made from your own blood cells to find and attack cancer. It is for adults with leukemia or lymphoma that has come back or is hard to treat.
MinskAges 18 years+ - NCT06960421Recruiting
Exercise program for people waiting for a lung transplant
This study tests a home-based exercise program to improve frailty in people waiting for a lung transplant. The program aims to help you become stronger and better prepared for surgery and recovery.
San Francisco, CaliforniaAges 18–75 - NCT00736749Recruiting
Long-term health check for childhood cancer survivors
This trial tracks the long-term health of people who took part in previous Children's Oncology Group studies. It helps doctors understand the lasting effects of cancer treatment and improve care for survivors.
Birmingham, AlabamaAges Any age - NCT03746769RecruitingPhase 1/Phase 2
Testing gastrin to improve results of islet cell transplant
This trial looks at whether adding gastrin can improve outcomes after an islet cell transplant for people with type 1 diabetes. It may help some participants achieve better blood sugar control, but it also requires close follow-up and immune-suppressing medications to protect the new cells.
Duarte, CaliforniaAges 18–68 - NCT06997016Enrolling by invitationPhase 4
Recovery program for living donor kidney transplant
This trial tests a special recovery program (ERAS) for people who get a kidney from a living donor. The program aims to help you heal faster and feel better after surgery.
Fort Worth, TexasAges 18 years+
Hear when a new Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for transplant?
- Yes. Clin2 currently lists 1,452 recruiting transplant studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a transplant trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a transplant trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.